Indeed, the normalized values of sCD163, a biomarker of macrophage activation in various inflammatory diseases (e.g., macrophage activation syndrome and sepsis), and during the development of T2DM [22,23] are consistent with the prevention observed in almost all pancreatic damage such as fibrosis, collagen, and immune infiltrations. The gene discussed is CD163; the disease is type 2 diabetes mellitus.